JP2023533617A5 - - Google Patents

Info

Publication number
JP2023533617A5
JP2023533617A5 JP2023524492A JP2023524492A JP2023533617A5 JP 2023533617 A5 JP2023533617 A5 JP 2023533617A5 JP 2023524492 A JP2023524492 A JP 2023524492A JP 2023524492 A JP2023524492 A JP 2023524492A JP 2023533617 A5 JP2023533617 A5 JP 2023533617A5
Authority
JP
Japan
Prior art keywords
aspartic acid
molar ratio
isoleucine
serine
threonine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023524492A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533617A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040090 external-priority patent/WO2022006397A1/en
Publication of JP2023533617A publication Critical patent/JP2023533617A/ja
Publication of JP2023533617A5 publication Critical patent/JP2023533617A5/ja
Pending legal-status Critical Current

Links

JP2023524492A 2020-07-02 2021-07-01 水分補給を促進するための製剤およびその使用方法 Pending JP2023533617A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063047300P 2020-07-02 2020-07-02
US63/047,300 2020-07-02
PCT/US2021/040090 WO2022006397A1 (en) 2020-07-02 2021-07-01 Formulations for promoting hydration and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023533617A JP2023533617A (ja) 2023-08-03
JP2023533617A5 true JP2023533617A5 (https=) 2024-07-08

Family

ID=79314908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023524492A Pending JP2023533617A (ja) 2020-07-02 2021-07-01 水分補給を促進するための製剤およびその使用方法

Country Status (11)

Country Link
US (2) US12357600B2 (https=)
EP (1) EP4175662A4 (https=)
JP (1) JP2023533617A (https=)
KR (1) KR20230047371A (https=)
CN (1) CN116194136A (https=)
AU (1) AU2021300188A1 (https=)
BR (1) BR112022027124A2 (https=)
CA (1) CA3184691A1 (https=)
IL (1) IL299488A (https=)
MX (1) MX2023000004A (https=)
WO (1) WO2022006397A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11878073B1 (en) * 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3916903A1 (de) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh Waessrige zusammensetzung fuer die parenterale ernaehrung
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
WO2010017403A2 (en) * 2008-08-06 2010-02-11 Immunopath Profile, Inc. Therapeutic compositions, devices and methods for observing treated tissues
JPWO2010041647A1 (ja) * 2008-10-06 2012-03-08 株式会社明治 アミノ酸組成物を有効成分として含む持久力向上剤、疲労防止剤、又は疲労回復剤
MX350541B (es) * 2010-09-24 2017-09-08 Univ Florida Materiales y metodos para mejorar la funcion gastrointestinal.
HK1204290A1 (en) * 2012-02-08 2015-11-13 University Of Florida Research Foundation, Inc. Materials and methods for treating diarrhea
MX2017006748A (es) * 2014-11-24 2017-08-28 Entrinsic Health Solutions Inc Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
CN115645388B (zh) * 2016-10-04 2024-12-10 佛罗里达大学研究基金会公司 氨基酸组合物及其用途
CN109218470B (zh) * 2017-07-05 2021-08-24 中兴通讯股份有限公司 移动终端及其控制方法
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA

Similar Documents

Publication Publication Date Title
ES2341767T3 (es) Quimioterapia de combinacion con clorotoxina.
ES2426485T3 (es) Composiciones farmacéuticas que comprenden hGH para administración oral
ES2932498T3 (es) Composiciones que comprenden el péptido WKDEAGKPLVK
CA2688766C (en) Compositions and methods for treatment of multiple sclerosis
JP6673924B2 (ja) 肝機能障害および/または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール
EP1750677B1 (en) Oral therapeutic compound delivery system
US10471142B2 (en) Combination therapy using immunoglobulin and C1-Inhibitor
JP2013515739A (ja) 血管形成関連の眼疾患の処置のための組成物および方法
JP2023500032A5 (https=)
Luyten et al. Yellow nail syndrome and onychomycosis: experience with itraconazole pulse therapy combined with vitamin E
JP5828609B2 (ja) 持続性解熱鎮痛消炎剤
JP2023533617A5 (https=)
JP2009242360A (ja) 経口用の慢性疼痛予防または治療剤
JP2017533967A (ja) システアミン組成物を用いるハンチントン病の処置方法
JP5865903B2 (ja) 経口鉄欠乏療法
RU2014126070A (ru) Способы лечения и предотвращения глазных заболеваний
KR101896441B1 (ko) 국소투여형의 연하장애 개선용 의약품
ES2612584T3 (es) Piroxicam para el tratamiento profiláctico y terapéutico de infecciones por herpes
ES2886106T3 (es) Dexmecamilamina para su uso en el tratamiento de la hiperhidrosis
ES2651537T3 (es) Tratamiento y prevención de la enfermedad de Alzheimer (AD)
RS57430B1 (sr) Mukoadhezivne bukalne tablete za lečenje orofacijalnog herpesa
JP5699030B2 (ja) エタネルセプトを含む線維筋痛症の治療剤
CN121360215A (zh) 达托霉素在制备非小细胞肺癌egfr-tki耐药的逆转剂中的应用
RU2498797C2 (ru) Комбинированное средство для лечения гриппа и орви
US20200339627A1 (en) Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof